Kyowa Kirin Co., Ltd. (4151) Gross Profit 2022–2025

Name: Kyowa Kirin Co., Ltd. (4151) gross profit history 2022-2025
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-11

Kyowa Kirin Co., Ltd. annual gross profit for fiscal 2025 was JPY 368.9 billion, an increase of 1.6% from JPY 362.9 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

4151 Annual Gross Profit

Gross Profit (annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Gross Profit	JPY 368.9B	JPY 362.9B	JPY 331.0B	JPY 311.5B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Gross Profit at Comparable Companies

4502 Gross Profit — Takeda Pharmaceutical Company Limited
4507 Gross Profit — Shionogi & Co., Ltd.
4523 Gross Profit — Eisai Co., Ltd.
4506 Gross Profit — Sumitomo Pharma Co., Ltd.
1276 Gross Profit — Jiangsu Hengrui Pharmaceuticals Co.,Ltd
4540 Gross Profit — Tsumura & Co.

More 4151 metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow

All 4151 financial statements → Interactive 4151 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.